Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

Background: Invasive candidiasis is increasingly prevalent in premature infants and seriously ill children, and pediatric data on available antifungal therapies are lacking. Methods: We conducted ...

Caspofungin was approved for use in Costa Rica in October 2001 (Cancidas; Merck Sharp and Dohme) for patients older than 16 years, with invasive Candida spp. or Aspergillus spp. that fail to ...

Fungal infections in India are rising, with growing resistance to treatment. Learn about common types, causes, drug ...

Desai, L. Kovanda - Poster P2946: Deciphering Connections Between Isavuconazole Drug Exposures and Responses Among Different Infections: Invasive Candidiasis – L. Kovanda, A. Desai - Poster ...

Candida auris is a species of fungus that can cause healthcare-associated invasive infections and outbreaks, posing a serious threat to global human health, according to Health Canada’s webpage ...

Cases of Candida auris, a dangerous, drug-resistant fungus, are rising in hospitals and senior care centers across the U.S.

Candidiasis is the term for an infection from Candida yeast. Invasive candidiasis is an infection inside your body. It can impact internal organs or other parts of your body. Acute hematogenous ...

Cidara Therapeutics, Inc.’s CDTX share price has dipped by 12.16%, which has investors questioning if this is right time to buy.